Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-033071
Filing Date
2023-11-27
Accepted
2023-11-27 17:29:31
Documents
3
Period of Report
2023-12-19

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A plse20231114_def14a.htm DEF 14A 236158
2 a01.jpg GRAPHIC 168799
3 a02.jpg GRAPHIC 157676
  Complete submission text file 0001437749-23-033071.txt   686727
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37744 | Film No.: 231441177
SIC: 3841 Surgical & Medical Instruments & Apparatus